| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 33 |
| 1 | CYCLOPHOSPHAMIDE | 24 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 24 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 24 |
| 4 | PREDNISONE | 24 |
| 5 | PREDNISOLONE | 18 |
| 6 | PREDNISOLONE ORAL | 18 |
| 7 | PREDNISOLONE ORAL SOLUTION | 18 |
| 8 | GEMCITABINE HYDROCHLORIDE | 15 |
| 9 | GEMCITABINE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PITAVASTATIN MAGNESIUM | 1 | 0.0169 |
| 1 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0021 |
| 2 | SILTUXIMAB | 1 | 0.0015 |
| 3 | PRALATREXATE | 1 | 0.0015 |
| 4 | BENDAMUSTINE HYDROCHLORIDE | 8 | 0.0009 |
| 5 | TOBRAMYCIN AND DEXAMETHASONE | 3 | 0.0009 |
| 6 | TOLNAFTATE | 1 | 0.0008 |
| 7 | BENDAMUSTINE HCL | 8 | 0.0005 |
| 8 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 9 | HYDROCORTISONE SODIUM SUCCINATE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 45 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 34 |
| 2 | Alkylating Drug [EPC] | 27 |
| 3 | Kinase Inhibitor [EPC] | 12 |
| 4 | Platinum-based Drug [EPC] | 11 |
| 5 | Azole Antifungal [EPC] | 7 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 7 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 6 |
| 9 | Benzodiazepine [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD30-directed Immunoconjugate [EPC] | 2 | 0.0002 |
| 2 | Antimalarial [EPC] | 2 | 0.0002 |
| 3 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 4 | Sulfone [EPC] | 2 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 6 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 27 | 0.0001 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 34 | 0.0001 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |